MBrace Therapeutics
Dawn C. has an extensive background in executive support, currently serving as the Executive Assistant to the Chief Executive Officer and Office Manager at MBrace Therapeutics since March 2022. Prior to this role, Dawn worked at Millennium Health from December 2017 to March 2022, providing support to the CEO, CFO, and CSO. Dawn's experience includes positions as an Executive Assistant at Human Longevity, Inc. from March 2015 to December 2017, Genomatica from May 2012 to March 2015, and DexCom from September 2008 to May 2012, where responsibilities involved senior executive support. Dawn began the career as an Executive Assistant at Akonix in 2007.
This person is not in any teams
MBrace Therapeutics
MBrace Therapeutics is a privately-held biopharmaceutical company devoted to improving the lives of cancer patients through the development of antibody-drug conjugates (ADCs) against novel oncology targets. MBrace is supported by a world-class investor syndicate, including TPG, Avidity Partners, Cowen Healthcare Investments, Venrock and Alta Partners.